When the immune system has become your enemy

A unique treatment for introducing immunological tolerance

Idogen develops tolerogenic cell therapies to prevent the patient’s immune system from attacking biological agents, transplanted organs or the body’s own cells or tissues.

Link to: Idogen´s technologyLink to: Stock informationLink to: Upcoming eventsLink to: Presentations and Interviews

Idogen´s technology enables development of tolerogenic cell therapy in a number of areas

Read more about our therapeutic areas:

Idogen develops tolerogenic cell therapy

Individualised treatment for each patient


Which information would you like to subscribe to?
Which information would you like to subscribe to?


Idogen avancerar mot kliniska studier
#BioStockSwe #LifeScience @IdogenAB https://www.biostock.se/2020/07/idogen-avancerar-mot-kliniska-studier/

Idogen appoints Åsa Schiött as new Chief Scientific Officer and Vicki Venizelos as Chief Regulatory Officer https://news.cision.com/se/idogen/r/idogen-appoints-asa-schiott-as-new-chief-scientific-officer-and-vicki-venizelos-as-chief-regulatory-,c3146236

Load More...